Exploration of KIR genes and hematological-related diseases in Chinese Han population
暂无分享,去创建一个
K. Du | Dai-yang Li | Z. Zheng | L. An | Ye-Mo Li | Yu-Xia Li | Xiao-Zhuang Hu | Zhi-Yang Yuan | Zhong-liang Liu
[1] Dajiang J. Liu,et al. Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE , 2022, BMC biology.
[2] Swe Swe Myint,et al. Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL , 2022, Blood advances.
[3] B. Walker,et al. An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults , 2021, PLoS pathogens.
[4] N. Geller,et al. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome , 2021, British journal of haematology.
[5] E. Gianchecchi,et al. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases? , 2021, Frontiers in Immunology.
[6] H. Nozad Charoudeh,et al. The role of KIR positive NK cells in diseases and its importance in clinical intervention. , 2021, International immunopharmacology.
[7] P. Chevallier,et al. Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation , 2020, Cancers.
[8] Nur Waliyuddin Hanis Zainal Abidin,et al. Understanding the genetic history of Malay populations in Peninsular Malaysia via KIR genes diversity , 2020, American journal of human biology : the official journal of the Human Biology Council.
[9] T. Reiman,et al. Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy , 2020, Frontiers in Immunology.
[10] He Huang,et al. Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation , 2020, Frontiers in Immunology.
[11] S. Ogawa,et al. Resistance of KIR Ligand–Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia , 2020, ImmunoHorizons.
[12] P. Parham,et al. HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity. , 2020, Annual review of biochemistry.
[13] S. Prakash,et al. Significance of KIR like natural killer cell receptors in autoimmune disorders. , 2020, Clinical immunology.
[14] Z. Deng,et al. KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han , 2020, BioMed research international.
[15] Jeffrey S. Miller,et al. Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia. , 2020, Blood advances.
[16] Wesley M. Marin,et al. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors , 2020, Frontiers in Immunology.
[17] M. J. Herrero,et al. Distribution of human killer cell immunoglobulin‐like receptors and ligands among blood donors of Catalonia , 2019, HLA.
[18] Z. Tian,et al. NK Cell Dysfunction and Checkpoint Immunotherapy , 2019, Front. Immunol..
[19] S. Sivori,et al. Report from the Eleventh Killer Immunoglobulin‐like Receptor (KIR) Workshop: Novel insights on KIR polymorphism, ligand recognition, expression and function , 2019, HLA.
[20] C. Caruso,et al. Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases. , 2018, Current pharmaceutical design.
[21] Shu-juan Ma,et al. Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations , 2017, Medicine.
[22] Wei Zhang,et al. Associations of killer cell immunoglobulin-like receptors with acute myeloid leukemia in Chinese populations. , 2017, Human immunology.
[23] J. Maciejewski,et al. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. , 2011, Mini reviews in medicinal chemistry.
[24] Smita Kulkarni,et al. The Yin and Yang of HLA and KIR in human disease. , 2008, Seminars in immunology.
[25] Li Yu,et al. The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people , 2008, International journal of hematology.
[26] A. Jankowska,et al. Analysis of Immunogenetic Factors in Myelodysplastic Syndromes (MDS) Reveals Potential Pathogenic Role Cytokine Genotypes Such as TGF-β. , 2007 .
[27] Qing-ping Liu,et al. [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. , 2007, Zhongguo shi yan xue ye xue za zhi.
[28] L. Luzzatto,et al. Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors. , 2005, Blood.
[29] S. Khakoo,et al. Hanging in the balance: KIR and their role in disease , 2005 .
[30] S. Kajigaya,et al. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. , 2004, Experimental hematology.
[31] T. Hsia,et al. Interleukin‐10 gene –627 allele variants, not interleukin‐I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma , 2003, Journal of clinical laboratory analysis.